Will BioNano Genomics Inc (BNGO) Stay at the Top of the Healthcare Sector?

A rating of 75 puts BioNano Genomics Inc (BNGO) near the top of the Healthcare sector according to InvestorsObserver. BioNano Genomics Inc's score of 75 means that it ranks higher than 75% of stocks in the sector. In addition, its overall score of 36 ranks it higher than 36% of all stocks.

BNGO has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on BNGO!

See Full BNGO Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 36 means the stock is more attractive than 36 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With BioNano Genomics Inc Stock Today?

BioNano Genomics Inc (BNGO) stock has gained 3.97% while the S&P 500 has fallen -0.54% as of 10:18 AM on Friday, Sep 17. BNGO is up $0.21 from the previous closing price of $5.29 on volume of 3,587,721 shares. Over the past year the S&P 500 has gained 32.55% while BNGO is up 773.02%. BNGO lost -$0.26 per share the over the last 12 months. Click Here to get the full Stock Report for BioNano Genomics Inc stock.